<DOC>
	<DOCNO>NCT01014117</DOCNO>
	<brief_summary>SRT2104 potent small molecule activator SIRT1 find inhibit systemic inflammation induce intravenous injection lipopolysaccharide ( LPS ) mouse . The objective study test SRT2104 may novel compound treatment inflammatory disorder man .</brief_summary>
	<brief_title>Effect SRT2104 Endotoxin-induced Inflammation</brief_title>
	<detailed_description />
	<criteria>Healthy , determine responsible experienced physician , base medical evaluation include medical history , physical examination laboratory test carry within 28 day prior day 1 . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure Male 18 35 year age inclusive , time signing informed consent Capable give write informed consent , include compliance requirement restriction list consent form No history HIV 1 2 , hepatitis B C Normal 12 lead ECG without clinically significant abnormality judge Investigator average QTcB QTcF &lt; 450 msec Normal renal liver function ( normal serum creatinine liver function test ( ALT , AST , Total bilirubin , alkaline phosphatase ) Subjects must agree partner use doublebarrier birth control abstinence participate study 12 week follow last dose study drug As result medical interview , physical examination screen investigation , Investigator appropriately qualify designee considers subject unfit study Subject major illness past three month significant chronic medial illness investigator would deem unfavourable enrolment include inflammatory disease Subjects history type malignancy exception successfully treat basal cell cancer skin Subject renal impairment Subject past current gastrointestinal disease may influence drug absorption The subject know positive test hepatitis C antibody hepatitis B surface antigen Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) The subject know positive test HIV antibody 1 2 Subject history , within three year , drug abuse ( include benzodiazepine , opioids , amphetamine , cocaine , THC ) positive drug result Screening visit History alcoholism and/or drink 3 drink per day . Alcoholism define average weekly intake &gt; 21 unit male &gt; 14 unit female . One unit equivalent 8 g alcohol : halfpint ( ~240 mL ) beer , 1 glass ( 125 mL ) wine 1 ( 25 mL ) measure spirit The subject participate clinical trial receive investigational product within three month first dose day current study Use prescription nonprescription drug , herbal dietary supplement within 7 day unless opinion Investigator Medical Monitor medication interfere study procedure compromise subject safety Subject difficultly donate blood accessibility vein leave right arm Subject donate 350 mL blood last 3 month Subject us tobacco product Any issue , opinion Principal Investigator , would could harmful subject compromise interpretation data</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>